MEC Plus Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Plus Events — 2025 MaTOS Breast 2025 MaTOS GU 2025 MCM 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MCM 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Type of Media — Video Document Audio Author / Speaker Title Search Entries: « 1 … 66 67 68 69 70 … 100 » How I Treat Advanced Head and Neck Cancer A. Dimitrios Colevas, MD View Video Castration Resistant Prostate Cancer: What is the optimal approach? Sandy Srinivas, MD View Video State of the Art: Hormone-sensitive Prostate Cancer Tanya Dorff, MD View Video AML: Current Status and Future Directions George Yaghmour, MD, FACP View Video Updates in Treatment of Lymphoma Joseph Tuscano, MD View Video MDS: State of the Art Paul Koller, MD View Video Keynote Lecture – The Future of Targeted Therapy in Lung Cancer Pasi A. Janne, MD, PhD View Video Updates in Treatment of Early Stage and Locally Advanced NSCLC Erminia Massarelli, MD, PhD, MS View Video Advances in Small Cell Lung Cancer and Mesothelioma Jorge Nieva, MD View Video Updates in Targeted Therapy for NSCLC Jonathan W. Riess, MD, MS View Video Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers David Gandara, MD View Video Esophageal and Gastric Cancer: New Developments George Fisher, MD, PhD View Video Pancreatic Cancer: Emerging Strategies Vincent Chung, MD, FACP View Video Progress in CAR-T Cell Therapies Stephen Forman, MD View Video Management of Immune Related Adverse Events Alicia Rigby, RN, MSN, FNP, AOCNP View Video Immunotherapy in Cancer: Next Generation Biomarkers Peter Lee, MD View Video How I treat Stage III NSCLC Karen Kelly, MD View Video PK and PD Considerations in Early Phase Clinical Trials Tim Synold, PharmD View Video Statistical Considerations in Early Phase Clinical Trial Design in the Era of Targeted Therapy and Immunotherapy Mark Krailo, PhD View Video Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD View Video Small Cell Lung Cancer Millie Das, MD View Video Other Immunotherapy Targets & Agents- Advanced NSCLC Nathaniel Myall, MD, MS View Video PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC Jonathan W. Riess, MD, MS View Video Other Oncogene-Driven Cancers Collin Blakely, MD, PhD View Video EGFR Mutated Lung Cancer - Advanced Stage David Gandara, MD View Video ALK, ROS1, and BRAF Positive Lung Cancer Joel Neal, MD, PhD View Video Tumor Biology, Pathology, Novel Diagnostics Tianhong “Tina” Li, MD, PhD View Video Stage III NSCLC – Surgical/Combined Modality Leah Backhus, MD View Video Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy Primo Lara, Jr, MD View Video Locally Advanced NSCLC- Radiation Therapy Sue Yom, MD, PhD View Video ← Previous View We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
